|
|
|
Insider
Information: |
Caforio Giovanni |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
435,474 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$18,903,062 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
435,474 |
|
|
Total
Value |
$18,903,062 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
5
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
Percentage
Gain/Loss : |
0.0%
|
1.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
Executive Chair of the... |
2024-03-10 |
432,266 |
|
0 |
Premium* |
|
Stryker Corp |
SYK |
Director |
2024-05-09 |
3,208 |
2023-05-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
|
2023-02-06 |
4 |
S |
$74.65 |
$17,916,000 |
D/D |
(240,000) |
236,104 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
|
2022-03-10 |
4 |
D |
$68.42 |
$10,871,254 |
D/D |
(158,890) |
606,524 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
|
2023-03-10 |
4 |
D |
$65.71 |
$9,067,257 |
D/D |
(137,989) |
367,935 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2018-03-10 |
4 |
D |
$67.92 |
$7,531,988 |
D/D |
(110,895) |
290,267 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2021-03-10 |
4 |
D |
$60.93 |
$6,838,357 |
D/D |
(112,233) |
553,980 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2020-03-10 |
4 |
D |
$57.93 |
$6,774,508 |
D/D |
(116,943) |
485,424 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2019-03-10 |
4 |
D |
$51.39 |
$4,415,018 |
D/D |
(85,912) |
365,199 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Executive Chair of the Board |
|
2024-03-10 |
4 |
D |
$53.79 |
$3,648,199 |
D/D |
(67,823) |
432,266 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
|
2022-09-15 |
4 |
S |
$71.84 |
$3,592,000 |
D/D |
(50,000) |
501,104 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2017-03-10 |
4 |
D |
$58.32 |
$2,611,686 |
D/D |
(44,782) |
172,418 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2020-08-31 |
4 |
S |
$62.70 |
$2,497,968 |
D/D |
(39,840) |
445,584 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
EVP & Chief Commercial Officer |
|
2014-02-24 |
4 |
S |
$54.36 |
$2,262,638 |
D/D |
(41,563) |
49,753 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2016-03-10 |
4 |
D |
$64.94 |
$2,174,581 |
D/D |
(33,486) |
110,648 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
|
2022-02-24 |
4 |
S |
$67.00 |
$2,010,000 |
D/D |
(30,000) |
453,455 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
|
2022-03-21 |
4 |
AS |
$71.52 |
$1,788,000 |
D/D |
(25,000) |
581,524 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
|
2022-09-20 |
4 |
AS |
$69.71 |
$1,742,750 |
D/D |
(25,000) |
476,104 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2021-03-22 |
4 |
AS |
$62.20 |
$1,555,000 |
D/D |
(25,000) |
528,980 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
|
2021-09-20 |
4 |
AS |
$60.64 |
$1,516,000 |
D/D |
(25,000) |
483,980 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
|
2021-08-02 |
4 |
S |
$68.58 |
$1,371,600 |
D/D |
(20,000) |
508,980 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
Chief Operating Officer |
|
2014-09-15 |
4 |
S |
$49.87 |
$1,331,155 |
D/D |
(26,691) |
40,755 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2013-05-23 |
4 |
S |
$46.29 |
$1,233,490 |
D/D |
(26,647) |
57,854 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-08-24 |
4 |
S |
$32.69 |
$846,671 |
D/D |
(25,900) |
57,260 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
|
2016-02-17 |
4 |
S |
$63.58 |
$765,527 |
D/D |
(12,040) |
76,738 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2013-01-28 |
4 |
S |
$36.19 |
$736,467 |
D/D |
(20,350) |
64,000 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
|
2012-08-24 |
4 |
OE |
$23.18 |
$705,925 |
D/D |
30,458 |
83,160 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|